AzTrials
AzTrials

Ridge AugmentationNCT05407363

Ridge Augmentation With Simultaneous Implant Placement Using Bone Blocks With Autogenous Tooth Graft

A study testing ABB and ATG with simultaneous implant placement, XBB and ATG with simultaneous implant placement and ABB and ABG with simultaneous implant placement in people with Ridge Augmentation and Implant, run by Kafrelsheikh University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Autogenous bone, with its osteogenic, osteoinductive, and osteo-conductive characteristics has been used for bone grafts with optimal integration into host tissues. For this reason, autogenous bone has been often considered the gold standard of bone regeneration material. Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
What is being tested?
ABB and ATG with simultaneous implant placement, XBB and ATG with simultaneous implant placement and ABB and ABG with simultaneous implant placement
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteEgypt
Study dates
1 Apr 2022to 20 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Teeth with buccal bone destruction by periodontal disease and need extraction (horizontal or vertical bone defect);
  • Absence of acute inflammation;
  • Absence of uncontrolled systemic illness that would preclude implantation;
  • Good dental and systemic healthy conditions;
  • Patients were willing and able to return for multiple follow-up visits.

Who cannot join

  • Patients with systemic illnesses,
  • psychological abnormalities,
  • para-functional habit,
  • smokers or alcoholics,
  • pregnant and lactating patients,
  • patients undergoing or recently completed radiotherapy or chemotherapy,
  • patients on drugs affecting the healing process,
  • patients with endodontically treated teeth

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry, Kafrelsheikh University

    Kafr ash Shaykh, 33511

Other trials in Egypt

About this study

Official title: Ridge Augmentation With Simultaneous Implant Placement Using Xenogenic Blocks or Autogenous Bone Blocks With Autogenous Tooth Graft

Autogenous bone, with its osteogenic, osteoinductive, and osteo-conductive characteristics has been used for bone grafts with optimal integration into host tissues. For this reason, autogenous bone has been often considered the gold standard of bone regeneration material. However, the amount of autogenous bone that may be harvested is limited, and the harvesting procedure is traumatic.

Bone substitutes, including allografts, xenografts, and alloplasts have been used successfully as alternatives to autogenous bone grafts in ridge augmentation procedures.

Read more

In 2008, autogenous tooth bone graft (ATG) was introduced and used for the first time as a bone grafting material for GBR. The tooth contents are extremely similar to that of the alveolar bone. The enamel inorganic, organic, and water contents are 95 percent, 0.6 percent, and 4 percent, respectively. However, in the dentin, the percentages are 70 to 75 percent, 20 percent, and 10 percent, respectively. They are 65 percent, 25 percent, and 10 percent, respectively, when compared to the alveolar bone content.

The aim of this study is to compare ridge augmentation using autogenous bone block (ABB) with immediate implant placement and filling the generated gap with autogenous bone graft (ABG) or ATG, or ridge augmentation using xenograft bone block (XBB) with immediate implant placement and filling the generated gap with ATG.

Being tested
ABB and ATG with simultaneous implant placement, XBB and ATG with simultaneous implant placement, ABB and ABG with simultaneous implant placement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ABB and ATG with simultaneous implant placementProcedure or surgery

    Ridge augmentation using ABB and ATG as a graft material with simultaneous implant placement

  • XBB and ATG with simultaneous implant placementProcedure or surgery

    Ridge augmentation using XBB and ATG as a graft material with simultaneous implant placement

  • ABB and ABG with simultaneous implant placementProcedure or surgery

    Ridge augmentation using ABB and ABG as a graft material with simultaneous implant placement

Study groups in NCT05407363
Study groupRoleWhat they receive
ABB and ATG with simultaneous implant placementExperimentalUsing ABB with ATG to fill the gap around simultaneously placed dental implants
Receives: Procedure: ABB and ATG with simultaneous implant placement
XBB and ATG with simultaneous implant placementExperimentalUsing XBB with ATG to fill the gap around simultaneously placed dental implants
Receives: Procedure: XBB and ATG with simultaneous implant placement
ABB and ABG with immediate implantActive comparatorUsing ABB with ABG to fill the gap around immediately placed dental implants
Receives: Procedure: ABB and ABG with simultaneous implant placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical evaluation probing pocket depth and amount of bone around simultaneously placed dental implants

    Changes on pocket depth and amount of bone using ABG or ATG with ABB or XBB around simultaneously placed dental implants

    Measured: 9 months

  2. radiographic outcome measuring the amount of bone around simultaneously placed dental implants

    the radiographic outcome by measuring the amount of bone by using ATG or ABG on bone formation with ABB or XBB around simultaneously placed dental implants

    Measured: 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2022
  2. Study start1 Apr 2022
  3. Primary completion12 Aug 2023
  4. Study completion20 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05407363
Sponsor's protocol ID
KFSIRB200-72
Status last verified
Dec 2023
First submitted
1 Apr 2022
Last updated
22 Dec 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing ABB and ATG with simultaneous implant placement, XBB and ATG with simultaneous implant placement and ABB and ABG with simultaneous implant placement in people with Ridge Augmentation and Implant, run by Kafrelsheikh University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical evaluation probing pocket depth and amount of bone around simultaneously placed dental implants (time frame: 9 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in